Enzo Biochem, Inc (NYSE:ENZ) has a beta value of 0.77 and has seen 0.16 million shares traded in the last trading session. The company, currently valued at $28.48M, closed the last trade at $0.55 per share which meant it gained $0.04 on the day or 6.88% during that session. The ENZ stock price is -132.73% off its 52-week high price of $1.28 and 25.45% above the 52-week low of $0.41. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.23 million shares traded. The 3-month trading volume is 176.12K shares.
Enzo Biochem, Inc (NYSE:ENZ) trade information
Sporting 6.88% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ENZ stock price touched $0.55 or saw a rise of 3.51%. Year-to-date, Enzo Biochem, Inc shares have moved -23.69%, while the 5-day performance has seen it change -2.66%. Over the past 30 days, the shares of Enzo Biochem, Inc (NYSE:ENZ) have changed -22.11%. Short interest in the company has seen 0.3 million shares shorted with days to cover at 2.56.
ENZ Dividends
Enzo Biochem, Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 0.10 at a share yield of 18.35%. The company’s dividend yield has gone up over the past 12 months.
Enzo Biochem, Inc (NYSE:ENZ)’s Major holders
Insiders own 22.60% of the company shares, while shares held by institutions stand at 32.55% with a share float percentage of 42.05%. Investors are also buoyed by the number of investors in a company, with Enzo Biochem, Inc having a total of 53.0 institutions that hold shares in the company. The top two institutional holders are HARBERT FUND ADVISORS, INC. with over 5.18 million shares worth more than $5.64 million. As of 2024-06-30, HARBERT FUND ADVISORS, INC. held 9.9072% of shares outstanding.
The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 2.5 million shares as of 2024-06-30. The firm’s total holdings are worth over $2.72 million and represent 4.8806% of shares outstanding.
